Topiramate is a medication used to manage and treat epilepsy and migraine, and it is in the second-generation anti-epileptic drugs class of drugs. In addition, Topiramate has approval for chronic weight management for individuals with a body mass index over 30. Topiramate received FDA approval in 1996 for treating epilepsy as monotherapy or adjunctive therapy. This activity will highlight the indications, mechanism of action, and adverse event profile pertinent to interprofessional team members in managing patients with epilepsy, migraine, and related conditions. It also lists other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions, toxicity, and monitoring related to topiramate therapy.

**Objectives:**
- Describe the mechanism of action of topiramate.
- Identify the indications of topiramate.
- Review the appropriate monitoring of topiramate.
- Outline some interprofessional team strategies for improving care coordination and communication to advance topiramate and improve outcomes.